1
|
Cavalieri D, Tournilhac O, Missiglia E, Bonnet C, Ledoux‐Pilon A, Bisig B, Cairoli A, Poullot E, Fataccioli V, Parrens M, Copin MC, Gutierrez FL, Xerri L, Bossard C, Wind R, Drieux F, Lhomme F, Daniel A, Clément‐Filliatre L, Lemmonier F, Morel P, Noël R, Brotelle T, Glaisner S, Sibon D, Yamani A, Bologna S, Queru K, Damaj G, Letailleur V, Villemagne B, Fleck E, Dupont E, Tchernonog E, Monjanel H, Wilde V, Vallois D, Gaulard P, Leval L. MONOMORPHIC EPITHELIOTROPIC INTESTINAL T‐CELL LYMPHOMA (MEITL): CLINICO‐PATHOLOGICAL ANALYSIS OF A MULTICENTER EUROPEAN COHORT. Hematol Oncol 2021. [DOI: 10.1002/hon.44_2879] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
2
|
Bachelard A, Isernia V, Vallois D, Le Gac S, Chalal L, Landman R, Damond F, Descamps D, Yazdanpanah Y, Peytavin G, Ghosn J. Efficacy and tolerability of combined antiretroviral treatment with bictegravir/emtricitabine/tenofovir alafenamide initiated at the time of primary HIV infection. J Antimicrob Chemother 2021; 76:2484-2485. [PMID: 34109414 DOI: 10.1093/jac/dkab192] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- A Bachelard
- AP-HP, Hospital Bichat-Claude-Bernard, Infectious and Tropical Diseases, Paris, France
| | - V Isernia
- AP-HP, Hospital Bichat-Claude-Bernard, Infectious and Tropical Diseases, Paris, France
| | - D Vallois
- AP-HP, Hospital Bichat-Claude-Bernard, Infectious and Tropical Diseases, Paris, France
| | - S Le Gac
- AP-HP, Hospital Bichat-Claude-Bernard, Infectious and Tropical Diseases, Paris, France
| | - L Chalal
- AP-HP, Hospital Bichat-Claude-Bernard, Infectious and Tropical Diseases, Paris, France
| | - R Landman
- AP-HP, Hospital Bichat-Claude-Bernard, Infectious and Tropical Diseases, Paris, France.,IAME-UMR 1137 INSERM, Université de Paris, Paris, France
| | - F Damond
- AP-HP, Hospital Bichat-Claude Bernard, Virology Laboratory, Paris, France
| | - D Descamps
- IAME-UMR 1137 INSERM, Université de Paris, Paris, France.,AP-HP, Hospital Bichat-Claude Bernard, Virology Laboratory, Paris, France
| | - Y Yazdanpanah
- AP-HP, Hospital Bichat-Claude-Bernard, Infectious and Tropical Diseases, Paris, France.,IAME-UMR 1137 INSERM, Université de Paris, Paris, France
| | - G Peytavin
- IAME-UMR 1137 INSERM, Université de Paris, Paris, France.,AP-HP, Hospital Bichat-Claude Bernard, Pharmacology-Toxicology Laboratory, Paris, France
| | - J Ghosn
- AP-HP, Hospital Bichat-Claude-Bernard, Infectious and Tropical Diseases, Paris, France.,IAME-UMR 1137 INSERM, Université de Paris, Paris, France
| |
Collapse
|
3
|
Vallois D, Missiaglia E, Bisig B, Juilland MF, Miazza MT, Leval L. RHOA G17V POTENTIATES CD28 T195P MUTATION INDUCED NFAT TRANSCRIPTIONAL ACTIVITY UPON CD3/CD28 STIMULATION. Hematol Oncol 2021. [DOI: 10.1002/hon.45_2879] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- D. Vallois
- Lausanne University Hospital and Lausanne University Institute of Pathology Lausanne Switzerland
| | - E. Missiaglia
- Lausanne University Hospital and Lausanne University Institute of Pathology Lausanne Switzerland
| | - B. Bisig
- Lausanne University Hospital and Lausanne University Institute of Pathology Lausanne Switzerland
| | | | - M. Thome Miazza
- Lausanne University Department of Biochemistry Epalinges Switzerland
| | - L. Leval
- Lausanne University Hospital and Lausanne University Institute of Pathology Lausanne Switzerland
| |
Collapse
|
4
|
Bachelard A, Isernia V, Vallois D, Le Gac S, Chalal L, Landman R, Le Hingrat Q, Yazdanpanah Y, Peytavin G, Ghosn J. Évaluation prospective de l’initiation d’un traitement antirétroviral par l’association TAF/FTC/BIC au stade de la primo-infection VIH. Med Mal Infect 2020. [DOI: 10.1016/j.medmal.2020.06.407] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
5
|
Bleibtreu A, Jaureguiberry S, Houhou N, Boutolleau D, Guillot H, Vallois D, Lucet JC, Robert J, Mourvillier B, Delemazure J, Jaspard M, Lescure FX, Rioux C, Caumes E, Yazdanapanah Y. Clinical management of respiratory syndrome in patients hospitalized for suspected Middle East respiratory syndrome coronavirus infection in the Paris area from 2013 to 2016. BMC Infect Dis 2018; 18:331. [PMID: 30012113 PMCID: PMC6048819 DOI: 10.1186/s12879-018-3223-5] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2017] [Accepted: 06/28/2018] [Indexed: 11/15/2022] Open
Abstract
Background Patients with suspected Middle East respiratory syndrome coronavirus (MERS-CoV) infection should be hospitalized in isolation wards to avoid transmission. This suspicion can also lead to medical confusion and inappropriate management of acute respiratory syndrome due to causes other than MERS-CoV. Methods We studied the characteristics and outcome of patients hospitalized for suspected MERS-CoV infection in the isolation wards of two referral infectious disease departments in the Paris area between January 2013 and December 2016. Results Of 93 adult patients (49 male (52.6%), median age 63.4 years) hospitalized, 82 out of 93 adult patients had returned from Saudi Arabia, and 74 of them were pilgrims (Hajj). Chest X-ray findings were abnormal in 72 (77%) patients. The 93 patients were negative for MERS-CoV RT-PCR, and 70 (75.2%) patients had documented infection, 47 (50.5%) viral, 22 (23.6%) bacterial and one Plasmodium falciparum malaria. Microbiological analysis identified Rhinovirus (27.9%), Influenza virus (26.8%), Legionella pneumophila (7.5%), Streptococcus pneumoniae (7.5%), and non-MERS-coronavirus (6.4%). Antibiotics were initiated in 81 (87%) cases, with two antibiotics in 63 patients (67.7%). The median duration of hospitalization and isolation was 3 days (1–33) and 24 h (8–92), respectively. Time of isolation decreased over time (P < 0.01). Two patients (2%) died. Conclusion The management of patients with possible MERS-CoV infection requires medical facilities with trained personnel, and rapid access to virological results. Empirical treatment with neuraminidase inhibitors and an association of antibiotics effective against S. pneumoniae and L. pneumophila are the cornerstones of the management of patients hospitalized for suspected MERS-CoV infection. Electronic supplementary material The online version of this article (10.1186/s12879-018-3223-5) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- A Bleibtreu
- APHP, Hôpital Bichat Claude Bernard, Service des Maladies Infectieuses et Tropicales, Paris Diderot University, Paris, France. .,APHP, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Service des Maladies Infectieuses et Tropicales, Paris, France. .,INSERM, IAME, UMR 1137, Paris, France. .,Univ Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, Paris, France.
| | - S Jaureguiberry
- APHP, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Service des Maladies Infectieuses et Tropicales, Paris, France
| | - N Houhou
- Virology Department, APHP-Bichat-Claude Bernard Hospital, Paris, France
| | - D Boutolleau
- AP-HP, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Service de Virologie, et Sorbonne Universités, UPMC Univ Paris 06, CR7, CIMI, INSERM U1135, Paris, France
| | - H Guillot
- APHP, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Service des Maladies Infectieuses et Tropicales, Paris, France
| | - D Vallois
- APHP, Hôpital Bichat Claude Bernard, Service des Maladies Infectieuses et Tropicales, Paris Diderot University, Paris, France
| | - J C Lucet
- APHP, Infection control unit, Bichat Claude Bernard hospital, Paris Diderot University, Paris, France.,INSERM, IAME, UMR 1137, Paris, France.,Univ Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, Paris, France
| | - J Robert
- AP-HP, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Bactériologie-Hygiène Hospitalière, Paris, France.,Faculté de Médecine P. & M. Curie Paris-6 - Site Pitié, Centre d'Immunologie et des Maladies Infectieuses (CIMI) - E13, Paris, France
| | - B Mourvillier
- INSERM, IAME, UMR 1137, Paris, France.,Univ Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, Paris, France.,APHP- Hôpital Bichat Claude Bernard, Service de Réanimation médicale et Infectieuse, Paris, France
| | - J Delemazure
- Service de pneumologie et réanimation Département R3S, AP-HP, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, unité de Soin de Réadaptation Post Réanimation (SRPR), Paris, France
| | - M Jaspard
- APHP, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Service des Maladies Infectieuses et Tropicales, Paris, France
| | - F X Lescure
- APHP, Hôpital Bichat Claude Bernard, Service des Maladies Infectieuses et Tropicales, Paris Diderot University, Paris, France.,INSERM, IAME, UMR 1137, Paris, France.,Univ Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, Paris, France
| | - C Rioux
- APHP, Hôpital Bichat Claude Bernard, Service des Maladies Infectieuses et Tropicales, Paris Diderot University, Paris, France
| | - E Caumes
- APHP, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Service des Maladies Infectieuses et Tropicales, Paris, France
| | - Y Yazdanapanah
- APHP, Hôpital Bichat Claude Bernard, Service des Maladies Infectieuses et Tropicales, Paris Diderot University, Paris, France.,INSERM, IAME, UMR 1137, Paris, France.,Univ Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité, Paris, France
| |
Collapse
|
6
|
Vallois D, Dupuy A, Lemonnier F, Fataccioli V, Ortonne N, Allen G, Tournilhac O, Delarue R, Rousselet-Chapeau M, Fabiani B, Llamas-Gutierrez F, Ko Y, Kataoka K, Gaulard P, de Leval L. TANSLOCATIONS INVOLVING CD28
ARE RARE IN PERIPHERAL T-CELL LYMPHOMAS. Hematol Oncol 2017. [DOI: 10.1002/hon.2438_22] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- D. Vallois
- Institute of Pathology; Centre Hospitalier Universitaire Vaudois; Lausanne Switzerland
| | - A. Dupuy
- Département de Pathologie, INSERM U955, Hôpital Henri-Mondor; Créteil France
| | - F. Lemonnier
- Département de Pathologie, INSERM U955, Hôpital Henri-Mondor; Créteil France
| | - V. Fataccioli
- Département de Pathologie, INSERM U955, Hôpital Henri-Mondor; Créteil France
| | - N. Ortonne
- Département de Pathologie, INSERM U955, Hôpital Henri-Mondor; Créteil France
| | - G. Allen
- Institute of Pathology; Centre Hospitalier Universitaire Vaudois; Lausanne Switzerland
| | - O. Tournilhac
- Hématologie Clinique; CHU Estaing; Clermont-Ferrand France
| | - R. Delarue
- Hématologie Clinique; HU-Necker enfants malades; Paris France
| | | | - B. Fabiani
- Anatomie et Cytologie Pathologiques; Hôpital Saint-Antoine; Paris France
| | | | - Y.H. Ko
- Department of Pathology; Samsung Medical Center; Seoul South Korea
| | - K. Kataoka
- Department of Pathology and Tumor Biology; Kyoto University; Kyoto Japan
| | - P. Gaulard
- Département de Pathologie, INSERM U955, Hôpital Henri-Mondor; Créteil France
| | - L. de Leval
- Institute of Pathology; Centre Hospitalier Universitaire Vaudois; Lausanne Switzerland
| |
Collapse
|
7
|
Lehur AC, Zielinski M, Pluvy J, Grégoire V, Diamantis S, Bleibtreu A, Rioux C, Picard A, Vallois D. Case of disseminated histoplasmosis in a HIV-infected patient revealed by nasal involvement with maxillary osteolysis. BMC Infect Dis 2017; 17:328. [PMID: 28476105 PMCID: PMC5418854 DOI: 10.1186/s12879-017-2419-4] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2016] [Accepted: 04/25/2017] [Indexed: 11/10/2022] Open
Abstract
Background Disseminated Histoplasmosis (DH) is a rare manifestation of Acquired Immune Deficiency Syndrome (AIDS) in European countries. Naso-maxillar osteolysis due to Histoplasma capsulatum var. capsulatum (Hcc) is unusual in endemic countries and has never been reported in European countries. Differential diagnoses such as malignant tumors, cocaine use, granulomatosis, vasculitis and infections are more frequently observed and could delay and/or bias the final diagnosis. Case presentation We report the case of an immunocompromised patient infected by Human Immunodeficiency Virus (HIV) with naso-maxillar histoplasmosis in a non-endemic country. Our aim is to describe the clinical presentation, the diagnostic and therapeutic issues. A 53-year-old woman, originated from Haiti, was admitted in 2016 for nasal deformation with alteration of general condition evolving for at least 6 months. HIV infection was diagnosed in 2006 and classified at AIDS stage in 2008 due to cytomegalovirus infection associated with pulmonary histoplasmosis. At admission, CD4 cell count was 9/mm3. Surgical biopsies were performed and ruled out differential or associated diagnoses. Mycological cultures identified Hcc and Blood Polymerase Chain Reaction (PCR) for Hcc was positive. The patient was given daily Amphothericin B liposomal infusion during 1 month. Hcc PCR became negative in the blood under treatment, and then oral switch by itraconazole was introduced. Antiretroviral treatment was reintroduced after a 3-week histoplasmosis treatment. Normalization of naso-maxillar mucosa enabled a palatal prosthesis. Conclusion Naso-maxillar histoplasmosis is extremely rare; this is the first case ever reported in a non-endemic country. Differential diagnoses must be ruled out by conducting microbiologic tools and histological examinations on surgical biopsies. Early antifungal treatment should be initiated in order to prevent DH severe outcomes.
Collapse
Affiliation(s)
- A C Lehur
- Infectious and Tropical Diseases Department, University Hospital Bichat-Claude Bernard, APHP, 46 rue Henri Huchard, 75018, Paris, France
| | - M Zielinski
- Otorhinolaryngology Department, University Hospital Bichat-Claude Bernard, APHP, Paris, France
| | - J Pluvy
- Infectious and Tropical Diseases Department, University Hospital Bichat-Claude Bernard, APHP, 46 rue Henri Huchard, 75018, Paris, France
| | - V Grégoire
- Hematology Department, Meaux Hospital, Meaux, France
| | - S Diamantis
- General Medecine and Infectious Diseases Department, Melun Hospital, Melun, France
| | - A Bleibtreu
- Infectious and Tropical Diseases Department, University Hospital Bichat-Claude Bernard, APHP, 46 rue Henri Huchard, 75018, Paris, France
| | - C Rioux
- Infectious and Tropical Diseases Department, University Hospital Bichat-Claude Bernard, APHP, 46 rue Henri Huchard, 75018, Paris, France
| | - A Picard
- Otorhinolaryngology Department, University Hospital Bichat-Claude Bernard, APHP, Paris, France
| | - D Vallois
- Infectious and Tropical Diseases Department, University Hospital Bichat-Claude Bernard, APHP, 46 rue Henri Huchard, 75018, Paris, France.
| |
Collapse
|
8
|
Bleibtreu A, Arias P, Vallois D, Debit A, Lermuzeaux M, Rioux C, Cabras O, Lucet JC, Choquet C, Timsit JF, Yazdanpanah Y, Lescure FX. Delayed management of Staphyloccocus aureus infective endocarditis in a Middle East respiratory syndrome coronavirus possible case hospitalized in 2015 in Paris, France. Clin Microbiol Infect 2016; 23:416-417. [PMID: 27986520 PMCID: PMC7129370 DOI: 10.1016/j.cmi.2016.11.021] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2016] [Revised: 11/28/2016] [Accepted: 11/29/2016] [Indexed: 12/04/2022]
Affiliation(s)
- A Bleibtreu
- AP-HP, Bichat Hospital, Department of Infectious and Tropical Diseases, Paris, France; Inserm, IAME, UMR 1137, Paris, France.
| | - P Arias
- AP-HP, Bichat Hospital, Department of Infectious and Tropical Diseases, Paris, France
| | - D Vallois
- AP-HP, Bichat Hospital, Department of Infectious and Tropical Diseases, Paris, France
| | - A Debit
- Emergency Departement Hôpital Bichat Claude Bernard, APHP, Paris, France
| | - M Lermuzeaux
- Intensive Care Unit, Hôpital Bichat Claude Bernard, APHP, Paris, France
| | - C Rioux
- AP-HP, Bichat Hospital, Department of Infectious and Tropical Diseases, Paris, France
| | - O Cabras
- AP-HP, Bichat Hospital, Department of Infectious and Tropical Diseases, Paris, France
| | - J C Lucet
- Inserm, IAME, UMR 1137, Paris, France; AP-HP, Bichat Hospital, Infection Control Unit, France
| | - C Choquet
- Emergency Departement Hôpital Bichat Claude Bernard, APHP, Paris, France
| | - J F Timsit
- Intensive Care Unit, Hôpital Bichat Claude Bernard, APHP, Paris, France
| | - Y Yazdanpanah
- AP-HP, Bichat Hospital, Department of Infectious and Tropical Diseases, Paris, France; Inserm, IAME, UMR 1137, Paris, France
| | - F X Lescure
- AP-HP, Bichat Hospital, Department of Infectious and Tropical Diseases, Paris, France; Inserm, IAME, UMR 1137, Paris, France
| |
Collapse
|
9
|
Collarino R, Vergeylen U, Emeraud C, Latournèrie G, Grall N, Mammeri H, Messika-Zeitoun D, Vallois D, Yazdanpanah Y, Lescure FX, Bleibtreu A. Mitral endocarditis due to Rothia aeria with cerebral haemorrhage and femoral mycotic aneurysms, first French description. New Microbes New Infect 2016; 13:40-2. [PMID: 27408740 PMCID: PMC4927642 DOI: 10.1016/j.nmni.2016.06.004] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2016] [Revised: 06/02/2016] [Accepted: 06/06/2016] [Indexed: 11/16/2022] Open
Abstract
Rothia aeria is a Rothia species from the Micrococcaceae family. We report here the first French R. aeria endocarditis complicated by brain haemorrhage and femoral mycotic aneurysms. Altogether, severity and antimicrobial susceptibility should make us consider the management of R. aeria endocarditis as Staphylococcus aureus methicillin-susceptible endocarditis.
Collapse
Affiliation(s)
- R Collarino
- Infectious and Tropical Diseases Department, University Hospital Bichat-Claude Bernard, APHP, Paris, France
| | - U Vergeylen
- Cardiology Departments, University Hospital Bichat-Claude Bernard, APHP, Paris, France
| | - C Emeraud
- Bacteriology Departments, University Hospital Bichat-Claude Bernard, APHP, Paris, France
| | - G Latournèrie
- Infectious and Tropical Diseases Department, University Hospital Bichat-Claude Bernard, APHP, Paris, France
| | - N Grall
- Bacteriology Departments, University Hospital Bichat-Claude Bernard, APHP, Paris, France
| | - H Mammeri
- Bacteriology Departments, University Hospital Bichat-Claude Bernard, APHP, Paris, France
| | - D Messika-Zeitoun
- Cardiology Departments, University Hospital Bichat-Claude Bernard, APHP, Paris, France
| | - D Vallois
- Infectious and Tropical Diseases Department, University Hospital Bichat-Claude Bernard, APHP, Paris, France
| | - Y Yazdanpanah
- Infectious and Tropical Diseases Department, University Hospital Bichat-Claude Bernard, APHP, Paris, France
| | - F-X Lescure
- Infectious and Tropical Diseases Department, University Hospital Bichat-Claude Bernard, APHP, Paris, France
| | - A Bleibtreu
- Infectious and Tropical Diseases Department, University Hospital Bichat-Claude Bernard, APHP, Paris, France
| |
Collapse
|
10
|
D’Ortenzio E, Brichler S, Dorchies J, Matra R, Eme A, Houhou N, Vallois D, Leparc-Goffart I, Yazdanpanah Y, Matheron S. TROP-03 - Arboviroses et voyageurs : l’expérience d’une consultation de pathologies tropicales. Med Mal Infect 2016. [DOI: 10.1016/s0399-077x(16)30511-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|